FDA yet to improve safety after Vioxx scandal
The FDA still hasn’t restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal.

The FDA still hasn’t restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal.
Vioxx study says heart risk falls when drug is stopped
New data show that cardiovascular risks from the recalled pain reliever Vioxx decreased after patients stopped taking it, a result Merck & Co. Inc. said undermined the claims of some heart-attack sufferers.
U.S. court in Louisiana to handle Vioxx cases (AlertNet)
NEW YORK, Feb 16 (Reuters) - Merck and Co. Inc.
Vioxx maker scores 4th legal victory
A Tennessee man's claim that the maker of the painkiller Vioxx should be blamed for his 2003 heart attack was rejected yester day by a federal jury, the fourth victory for Merck & Co. in five federal trials.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved